loans will largely be balanced out by lower taxes on its U.S. sales. From Actavis to Allergan: One pharma company's wild dealmaking journey. Forbes Magazine
Fortune. [2020-07-12]. (原始内容存档于2020-07-26) (英语). Celgene, Kinder Morgan and Actavis Set to Join the S&P 100; Several Constituent Changes Announced for S&P